The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
¿Qué es una tecnología sanitaria eficiente en España?
Open accessAbstract
A pesar del creciente reconocimiento de la potencial utilidad de los estudios de coste-efectividad, en España no existe ningún criterio que permita establecer si una determinada tecnología sanitaria puede considerarse rentable o no. El objetivo de este trabajo es describir cuáles han sido los límites y criterios utilizados en España para recomendar la adopción o el rechazo de intervenciones sanitarias en función de su coste-efectividad. Se realizó una revisión de las evaluaciones económicas de intervenciones sanitarias publicadas en España desde 1990 hasta 2001. Se seleccionaron las evaluaciones económicas completas en las que el cociente coste-efectividad se había expresado como coste por año de vida ganado (AVG), como coste por año de vida ajustado por calidad (AVAC) o como coste por vida salvada. Se analizaron las intervenciones sobre las que los autores establecieron algún tipo de recomendación (de adopción o rechazo), así como los criterios utilizados. Veinte (20%) de las 100 evaluaciones económicas completas publicadas cumplieron con los criterios señalados. En 16 de los estudios, los resultados se expresaron como coste por AVG, en 6 como coste por AVAC y en 1 como coste por vida salvada. Se evaluaron un total de 82 intervenciones sanitarias, en 44 de las cuales se realizó algún tipo de recomendación. Los autores recomendaron la adopción de todas las intervenciones sanitarias con un coste-efectividad inferior a 30.000 euros (5 millones de pesetas) por AVG. Por encima de esa cifra no se apreció ninguna tendencia. Si bien los resultados deben ser interpretados con mucha precaución, dadas las limitaciones del estudio, los límites de coste-efectividad presentados en este trabajo podrían constituir una primera referencia a lo que podría considerarse como una intervención sanitaria eficiente en España. Despite the growing recognition of the potential applications of cost-effectiveness assessments, a criterion to establish what is an efficient health technology does not exist in Spain. The objective of this work is to describe the limits and the criteria used in Spain to recommend the adoption of health interventions. A review of the economic evaluations of health technologies published in Spain from 1990 to 2001 was conducted. Complete economic assessments in which the costeffectiveness ratio was expressed as cost per life-year gained (LYG), cost per quality-adjusted-life-year (QALY) or cost per saved live were selected. Those interventions in which the authors established recommendations (adoption or rejection) and the criteria used were analyzed. Twenty (20%) of the 100 complete economic evaluations fulfilled the selection criteria. In16 studies, the results were expressed as cost per LYG, in 6 studies as cost per QALY and in 1 as cost per saved live. A total of 82 health interventions were assessed and some kind of recommendation was established in 44 of them. All technologies with a cost-effectiveness ratio lower than 30,000 euros (5 million pesetas) per LYG were recommended for adoption by the authors. Up to that limit there was no a clear tendency. Although the results must be interpreted with much precaution, given the limitations of the study, the limits of cost-effectiveness presented in this work could be a first reference to which would be an efficient health intervention in Spain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Laupacis, A., Feeny, D. H., Detsky, A. S., & Tugwell, P. (1992) · Europe PMC (PubMed Central) · Cited by 1,581
Economics notes: Definitions of efficiency
Palmer, S., & Torgerson, D. J. (1999) · BMJ · doi:10.1136/bmj.318.7191.1136 · Cited by 286
Cost-Effectiveness Analysis in a Setting of Budget Constraints — Is It Equitable?
Ubel, P. A., DeKay, M. L., Baron, J., & Asch, D. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341807 · Cited by 223
A Comprehensive League Table of Cost-Utility Ratios and a Sub-table of "Panel-worthy" Studies
Chapman, R. H., Stone, P. W., Sandberg, E. A., Bell, C., & Neumann, P. J. (2000) · Medical Decision Making · doi:10.1177/0272989x0002000409 · Cited by 165
Añón, J. M., de Lorenzo, A. G., Zarazaga, A., Gómez-Tello, V., & Cantarero, G. G. (1999) · Intensive Care Medicine · doi:10.1007/s001340050879 · Cited by 75
Interpretation of "Cost-Effective" and Soundness of Economic Evaluations in the Pharmacy Literature
Lee, J. T., & Sanchez, L. A. (1991) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/48.12.2622 · Cited by 71
Cost-Effectiveness of Cardiovascular Prevention Programs in Spain
Plans-Rubió, P. (1998) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300012289 · Cited by 55
Cost-Benefit Analysis of Haemophilus influenzae Type b Vaccination in Children in Spain
Jiménez, F. J., Guallar‐Castillón, P., Rubio‐Terres, C., & Güallar, E. (1999) · PharmacoEconomics · doi:10.2165/00019053-199915010-00005 · Cited by 26
Coste-efectividad del consejo sanitario antitabaco en atención primaria de salud
Fuentes, A. C., Gutiérrez, R. S., González, M. A. L. L., & Espinar, A. C. (1998) · Gaceta Sanitaria · doi:10.1016/s0213-9111(98)76457-x · Cited by 24
Cost-effectiveness of dietary treatment of hypercholesterolemia in Spain
Rubió, P. P. (1997) · Public Health · doi:10.1038/sj.ph.1900304 · Cited by 18
Cited by
Propuesta de guía para la evaluación económica aplicada a las tecnologías sanitarias
López Bastida, J., Oliva, J., Antoñanzas, F., García-Altés, A., Gisbert, R., Mar, J., & Puig-Junoy, J. (2010) · Gaceta Sanitaria · doi:10.1016/j.gaceta.2009.07.011 · Cited by 311
Self-citationBallesteros-Pomar, M., Martínez Llinàs, D., Goates, S., Sanz Barriuso, R., & Sanz-Paris, A. (2018) · Nutrients · doi:10.3390/nu10020246 · Cited by 30
Metadata
- Authors
- Sacristán, J. A., Oliva, J., Del Llano, J., Prieto, L., & Pinto, J. L.
- Venue
- Gaceta Sanitaria
- Publisher
- Elsevier BV
- Published
- 2002
- Volume
- 16
- Issue
- 4
- Pages
- 334-343
- ISSN
- 0213-9111 (ISSN-L)
- OpenAlex
- W2025029039
- Cited by
- 359
- References
- 10
- FWCI
- 16.75
- Type
- journal article
- Language
- es
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ¿Qué es una tecnología sanitaria eficiente en España? https://app.cochat.ai/papers/10.1016/s0213-9111(02)71933-x
- The paper
- Sacristán, J. A., Oliva, J., Del Llano, J., Prieto, L., & Pinto, J. L. (2002). ¿Qué es una tecnología sanitaria eficiente en España? Gaceta Sanitaria. https://doi.org/10.1016/s0213-9111(02)71933-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.